Market Cap 3.36B
Revenue (ttm) 376.07M
Net Income (ttm) -16.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 172.25
Profit Margin -4.29%
Debt to Equity Ratio 0.58
Volume 1,570,500
Avg Vol 1,594,792
Day's Range N/A - N/A
Shares Out 125.08M
Stochastic %K 10%
Beta 1.48
Analysts Strong Sell
Price Target $34.62

Company Profile

Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as...

Industry: Biotechnology
Sector: Healthcare
Phone: 805 418 5006
Address:
3027 Townsgate Road, Suite 300, Westlake Village, United States
Franciscomaligno
Franciscomaligno Aug. 3 at 4:49 PM
$ARQT expecially before earnings, always same story here !!!
0 · Reply
Franciscomaligno
Franciscomaligno Aug. 3 at 2:08 PM
$ARQT always same boring strategy acted by mf sob fa mm's!!! They try to scare forcing retail to sell. This one will be at$40 by EOY , DON'T SELL TO THIS BASTARD , SCUMBAG!!!
0 · Reply
Rhody27
Rhody27 Jul. 31 at 4:34 PM
$ARQT not selling MM's. Nice try.
0 · Reply
5StarTrader
5StarTrader Jul. 31 at 3:52 PM
$ARQT It wouldn’t surprise me to learn that the numbers have been leaked out to a few Club Members, who have put in some big purchase orders, which the MM Mafia filled with counterfeit shares grabbing a big fat fee. Now the MM Mafia all need to cover their naked short positions. Fortunately, they know that the way to make a big spread after selling fake shares at high prices is to buy real shares at cheap prices. Coincidentally, they know from history that by dropping their Bids they can get dummy retail investors to sell them their shares at cheap prices and they determine what their Bid & Ask prices will be. It’s called “Double Dipping”. I’m guessing you’re beginning to get the picture… “It’s a big club & you’re not in it.” George Carlin
0 · Reply
Plasma_star_9
Plasma_star_9 Jul. 31 at 2:06 PM
$ARQT Guess the word has leaked, less than stellar quartly earnings.
0 · Reply
Merlintrader
Merlintrader Jul. 30 at 6:20 AM
Merlintrader Stock Hub • Updated July 30, 2026 Arcutis Biotherapeutics (Nasdaq: $ARQT): ZORYVE’s Commercial Franchise, Pediatric Label Expansion and the Next FDA Catalyst https://www.merlintrader.com/arcutis-biotherapeutics-stock-hub/
0 · Reply
Bizzarro
Bizzarro Jul. 28 at 3:24 PM
0 · Reply
BoscoBob
BoscoBob Jul. 21 at 11:06 AM
$ARQT and the options i bought were at the worst time possible. i knew something was brewing lol. anyone else think we break 30 in the next 60 days? otherwise im kwinda screwed! oh man
2 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Jul. 18 at 10:23 PM
$ARQT Derm space ZORYVE sales (steroid free) Get the kids
2 · Reply
Doozio
Doozio Jul. 18 at 7:33 PM
$ARQT n da 🐑 are so worried about a crash being in cash because they are semi retarded with their bottlenecks up their bros while da huckleberries are below da $$ da DLO in 2026 ENTA 🐒🍌🧠⏰♾️
0 · Reply
Latest News on ARQT
Arcutis Biotherapeutics Transcript: AGM 2026

Jun 5, 2026, 10:30 AM EDT - 2 months ago

Arcutis Biotherapeutics Transcript: AGM 2026


Arcutis Biotherapeutics reports Q1 EPS (9c), consensus (6c)

2026-05-07T01:26:52.000Z - 3 months ago

Arcutis Biotherapeutics reports Q1 EPS (9c), consensus (6c)


Arcutis Biotherapeutics Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

Arcutis Biotherapeutics Earnings Call Transcript: Q1 2026


Arcutis Biotherapeutics Earnings release: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

Arcutis Biotherapeutics Earnings release: Q1 2026


Arcutis Biotherapeutics Quarterly report: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

Arcutis Biotherapeutics Quarterly report: Q1 2026


Arcutis Biotherapeutics Slides: Q1 2026

May 6, 2026, 4:30 PM EDT - 3 months ago

Arcutis Biotherapeutics Slides: Q1 2026


Arcutis Biotherapeutics Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 3 months ago

Arcutis Biotherapeutics Proxy statement: Proxy filing


Arcutis Biotherapeutics Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 3 months ago

Arcutis Biotherapeutics Proxy statement: Proxy filing


Arcutis Biotherapeutics Slides: Corporate presentation

Mar 31, 2026, 7:00 AM EDT - 4 months ago

Arcutis Biotherapeutics Slides: Corporate presentation


Arcutis Biotherapeutics files automatic mixed securities shelf

2026-02-25T21:51:17.000Z - 5 months ago

Arcutis Biotherapeutics files automatic mixed securities shelf


Arcutis Biotherapeutics Earnings Call Transcript: Q4 2025

Feb 25, 2026, 4:30 PM EST - 5 months ago

Arcutis Biotherapeutics Earnings Call Transcript: Q4 2025


Arcutis Biotherapeutics Annual report: Q4 2025

Feb 25, 2026, 4:30 PM EST - 5 months ago

Arcutis Biotherapeutics Annual report: Q4 2025


Arcutis Biotherapeutics Earnings release: Q4 2025

Feb 25, 2026, 4:30 PM EST - 5 months ago

Arcutis Biotherapeutics Earnings release: Q4 2025


Arcutis Biotherapeutics Slides: Q4 2025

Feb 25, 2026, 4:30 PM EST - 5 months ago

Arcutis Biotherapeutics Slides: Q4 2025


Arcutis Biotherapeutics reports Q4 EPS 13c, consensus 9c

2026-02-25T21:08:30.000Z - 5 months ago

Arcutis Biotherapeutics reports Q4 EPS 13c, consensus 9c


Arcutis Biotherapeutics Transcript: Q3 & Investor Day 2025

Oct 28, 2025, 10:30 AM EDT - 9 months ago

Arcutis Biotherapeutics Transcript: Q3 & Investor Day 2025


Arcutis Biotherapeutics Earnings release: Q3 2025

Oct 28, 2025, 10:30 AM EDT - 9 months ago

Arcutis Biotherapeutics Earnings release: Q3 2025


Arcutis Biotherapeutics Quarterly report: Q3 2025

Oct 28, 2025, 10:30 AM EDT - 9 months ago

Arcutis Biotherapeutics Quarterly report: Q3 2025


Arcutis Biotherapeutics Slides: Q3 2025

Oct 28, 2025, 10:30 AM EDT - 9 months ago

Arcutis Biotherapeutics Slides: Q3 2025


Arcutis to Present at Upcoming Investor Conferences

Oct 27, 2025, 4:00 PM EDT - 10 months ago

Arcutis to Present at Upcoming Investor Conferences


Arcutis Biotherapeutics Slides: Corporate Presentation

Oct 16, 2025, 7:00 AM EDT - 10 months ago

Arcutis Biotherapeutics Slides: Corporate Presentation


Arcutis Biotherapeutics Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Arcutis Biotherapeutics Earnings Call Transcript: Q2 2025


Arcutis Biotherapeutics Quarterly report: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Arcutis Biotherapeutics Quarterly report: Q2 2025


Arcutis Biotherapeutics Earnings release: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Arcutis Biotherapeutics Earnings release: Q2 2025


Arcutis Biotherapeutics Slides: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

Arcutis Biotherapeutics Slides: Q2 2025


Arcutis Biotherapeutics Earnings Call Transcript: Q1 2025

May 6, 2025, 4:30 PM EDT - 1 year ago

Arcutis Biotherapeutics Earnings Call Transcript: Q1 2025


Arcutis Biotherapeutics Quarterly report: Q1 2025

May 6, 2025, 4:30 PM EDT - 1 year ago

Arcutis Biotherapeutics Quarterly report: Q1 2025


Arcutis Biotherapeutics Earnings release: Q1 2025

May 6, 2025, 4:30 PM EDT - 1 year ago

Arcutis Biotherapeutics Earnings release: Q1 2025


Arcutis Biotherapeutics Slides: Q1 2025

May 6, 2025, 4:30 PM EDT - 1 year ago

Arcutis Biotherapeutics Slides: Q1 2025


Franciscomaligno
Franciscomaligno Aug. 3 at 4:49 PM
$ARQT expecially before earnings, always same story here !!!
0 · Reply
Franciscomaligno
Franciscomaligno Aug. 3 at 2:08 PM
$ARQT always same boring strategy acted by mf sob fa mm's!!! They try to scare forcing retail to sell. This one will be at$40 by EOY , DON'T SELL TO THIS BASTARD , SCUMBAG!!!
0 · Reply
Rhody27
Rhody27 Jul. 31 at 4:34 PM
$ARQT not selling MM's. Nice try.
0 · Reply
5StarTrader
5StarTrader Jul. 31 at 3:52 PM
$ARQT It wouldn’t surprise me to learn that the numbers have been leaked out to a few Club Members, who have put in some big purchase orders, which the MM Mafia filled with counterfeit shares grabbing a big fat fee. Now the MM Mafia all need to cover their naked short positions. Fortunately, they know that the way to make a big spread after selling fake shares at high prices is to buy real shares at cheap prices. Coincidentally, they know from history that by dropping their Bids they can get dummy retail investors to sell them their shares at cheap prices and they determine what their Bid & Ask prices will be. It’s called “Double Dipping”. I’m guessing you’re beginning to get the picture… “It’s a big club & you’re not in it.” George Carlin
0 · Reply
Plasma_star_9
Plasma_star_9 Jul. 31 at 2:06 PM
$ARQT Guess the word has leaked, less than stellar quartly earnings.
0 · Reply
Merlintrader
Merlintrader Jul. 30 at 6:20 AM
Merlintrader Stock Hub • Updated July 30, 2026 Arcutis Biotherapeutics (Nasdaq: $ARQT): ZORYVE’s Commercial Franchise, Pediatric Label Expansion and the Next FDA Catalyst https://www.merlintrader.com/arcutis-biotherapeutics-stock-hub/
0 · Reply
Bizzarro
Bizzarro Jul. 28 at 3:24 PM
0 · Reply
BoscoBob
BoscoBob Jul. 21 at 11:06 AM
$ARQT and the options i bought were at the worst time possible. i knew something was brewing lol. anyone else think we break 30 in the next 60 days? otherwise im kwinda screwed! oh man
2 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Jul. 18 at 10:23 PM
$ARQT Derm space ZORYVE sales (steroid free) Get the kids
2 · Reply
Doozio
Doozio Jul. 18 at 7:33 PM
$ARQT n da 🐑 are so worried about a crash being in cash because they are semi retarded with their bottlenecks up their bros while da huckleberries are below da $$ da DLO in 2026 ENTA 🐒🍌🧠⏰♾️
0 · Reply
johnnyutah007
johnnyutah007 Jul. 11 at 4:50 PM
$ARQT 👀
0 · Reply
Rhody27
Rhody27 Jul. 10 at 2:20 PM
$ARQT don’t sell to the MMs. This is going to $50 by EOY.
0 · Reply
fda_tracker
fda_tracker Jul. 9 at 6:51 PM
$ARQT New PDUFA Date 2027-02-23 Arcutis Biotherapeutics, Inc. Link: https://www.globenewswire.com/news-release/2026/07/08/3324020/0/en/fda-accepts-supplemental-new-drug-application-for-arcutis-zoryve-roflumilast-cream-0-05-for-the-treatment-of-mild-to-moderate-atopic-dermatitis-in-infants-down-to-3-months.html Calendar: http://www.fdatracker.com/fda-calendar/
0 · Reply
Merlintrader
Merlintrader Jul. 9 at 7:54 AM
$ARQT Arcutis Biotherapeutics (Nasdaq: $ARQT): ZORYVE’s Commercial Franchise, Pediatric Label Expansion and the Next FDA Catalyst https://www.merlintrader.com/arcutis-biotherapeutics-stock-hub/
0 · Reply
JFais
JFais Jul. 3 at 1:58 PM
Doing another one of these on Tuesday FYI @stevenvig Last one we discussed $GERN $ARQT $SNDX among others (also importance of combatting FOMO with fewer trades per month, rather timely with $XBI at highs) https://seekingalpha.com/article/4828961?gt=f9ee6019a90fb5fc
0 · Reply
Neutin
Neutin Jun. 30 at 2:58 PM
$ARQT Manipulation? Is that you? 🤓 Don't worry the price will be back up very soon
0 · Reply
Franciscomaligno
Franciscomaligno Jun. 30 at 2:28 PM
$ARQT ...and MMs hits Again. Really pos, sob , mf, and other thousand of theese is what they deserve!!!
0 · Reply
AlertsAndNews
AlertsAndNews Jun. 29 at 11:32 PM
$ARQT FDA approval here FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2
0 · Reply
TwongStocks
TwongStocks Jun. 29 at 11:14 PM
$ARQT FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2 https://www.globenewswire.com/news-release/2026/06/29/3319348/0/en/fda-approves-arcutis-zoryve-roflumilast-cream-0-3-for-the-treatment-of-plaque-psoriasis-in-children-as-young-as-age-2.html
0 · Reply
jcwhitey
jcwhitey Jun. 29 at 8:35 PM
$ARQT The FDA is the most inconsistent government organization that I know. How can they approve new drugs early that have never been on the market but forget about this drug? For crying out loud it's already on the market. FFS approve it for another indication.
0 · Reply
ixthus77
ixthus77 Jun. 29 at 7:32 PM
$ARQT Aprroximatley 5K-10K of children aged 2-5 in the U.S. experience plaque psoriasis in a given year. Not enough to move the needle revenue wise.
0 · Reply
Rhody27
Rhody27 Jun. 29 at 4:51 PM
$ARQT approval AH
0 · Reply